BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 17016721)

  • 21. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ewing's tumours, genetic and cellular aspects].
    Delattre O
    Pathol Biol (Paris); 2008 Jul; 56(5):257-9. PubMed ID: 18485618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.
    Aryee DN; Niedan S; Kauer M; Schwentner R; Bennani-Baiti IM; Ban J; Muehlbacher K; Kreppel M; Walker RL; Meltzer P; Poremba C; Kofler R; Kovar H
    Cancer Res; 2010 May; 70(10):4015-23. PubMed ID: 20442286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1.
    Lu Q; Lu M; Li D; Zhang S
    Mol Med Rep; 2018 Oct; 18(4):3577-3588. PubMed ID: 30106161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esophageal extraskeletal Ewing's sarcoma.
    Maesawa C; Iijima S; Sato N; Yoshinori N; Suzuki M; Tarusawa M; Ishida K; Tamura G; Saito K; Masuda T
    Hum Pathol; 2002 Jan; 33(1):130-2. PubMed ID: 11823984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
    Ban J; Siligan C; Kreppel M; Aryee D; Kovar H
    Adv Exp Med Biol; 2006; 587():41-52. PubMed ID: 17163154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells.
    Li X; Tanaka K; Nakatani F; Matsunobu T; Sakimura R; Hanada M; Okada T; Nakamura T; Iwamoto Y
    Int J Cancer; 2005 Sep; 116(3):385-94. PubMed ID: 15818598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for DAX1/EWS-FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma.
    Watanabe M; Kosaka H; Sugawara M; Maemoto M; Ono Y; Uemori T; Shizu R; Yoshinari K
    Cancer Med; 2023 Apr; 12(8):9802-9814. PubMed ID: 36825574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keratin-positive Ewing's sarcoma: an ultrastructural study of 12 cases.
    Srivastava A; Rosenberg AE; Selig M; Rubin BP; Nielsen GP
    Int J Surg Pathol; 2005 Jan; 13(1):43-50. PubMed ID: 15735854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and B.
    Winter GE; Rix U; Lissat A; Stukalov A; Müllner MK; Bennett KL; Colinge J; Nijman SM; Kubicek S; Kovar H; Kontny U; Superti-Furga G
    Mol Cancer Ther; 2011 Oct; 10(10):1846-56. PubMed ID: 21768330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adamantinoma-like Ewing Sarcoma of the thyroid gland: Cytomorphologic, phenotypic and molecular features.
    Chikeka I; Sung S; Tiscornia-Wasserman P; Cimic A
    Diagn Cytopathol; 2020 Nov; 48(11):1107-1110. PubMed ID: 32472960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ewing's sarcoma of the cervix: A case report and review of literature.
    Zhang Y; Nong W; Ren Y; Jiang J; Zhang H; Meng L; Li Q; Zhang Q; Wang X; Wang Y; Liu C; Li F
    Histol Histopathol; 2020 May; 35(5):475-480. PubMed ID: 31688946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adamantinoma-like Ewing sarcoma of the thyroid.
    Jones R; Maleki Z
    Diagn Cytopathol; 2020 Dec; 48(12):E4-E6. PubMed ID: 32558347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sinonasal adamantinoma-like Ewing sarcoma: A case report.
    Alexiev BA; Tumer Y; Bishop JA
    Pathol Res Pract; 2017 Apr; 213(4):422-426. PubMed ID: 28262274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extraskeletal Ewing's sarcoma in a 67-year-old man.
    Hanaoka N; Goto T; Kasai T; Matsuura T; Nishisho T; Enishi T; Yasui N
    J Orthop Sci; 2011 Mar; 16(2):250-2. PubMed ID: 21327980
    [No Abstract]   [Full Text] [Related]  

  • 36. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific and sensitive detection of the EWS/FLI1 fusion protein in Ewing's sarcoma by Western blotting.
    Wang M; Nilsson G; Carlberg M; Dricu A; Wejde J; Kreicbergs A; Larsson O
    Virchows Arch; 1998 Feb; 432(2):131-4. PubMed ID: 9504857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle.
    Asami S; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
    Biol Pharm Bull; 2008 Mar; 31(3):391-4. PubMed ID: 18310898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ewing's sarcoma of the hip presenting as a benign cystic lesion.
    Papagelopoulos PJ; Mavrogenis AF; Benetos IS; Papaparaskeva K; Galanis EC; Soucacos PN
    J Surg Orthop Adv; 2007; 16(2):84-8. PubMed ID: 17592716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis.
    Abaan OD; Levenson A; Khan O; Furth PA; Uren A; Toretsky JA
    Oncogene; 2005 Apr; 24(16):2715-22. PubMed ID: 15782144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.